New pharmacological agents for the treatment of gastro-oesophageal reflux disease
Prevention of non-steroidal anti-inflammatory drug gastrointestinal complications – review and recommendations based on risk assessment
Laboratory markers predict bone loss in Crohn's disease
Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation
Predicting the outcome of severe ulcerative colitis
Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide
Health-related quality of life in patients with cardiovascular disease – the effect of upper gastrointestinal symptom treatment
Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough
Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole
The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain – a randomized, double-blind, placebo-controlled, crossover trial
Management of defecation disorders with botulinum neurotoxin
Polyethylene glycol for constipation
Reply to Halphen, Letter to the Editor
Green tea
Reply to Brisinda et al. Letter to the Editor